|
市場調査レポート
商品コード
1126547
自動視野計の世界市場規模、シェア、産業動向分析レポート:最終用途別、タイプ別、用途別(緑内障、加齢黄斑変性、スコトーマ)、地域別展望と予測、2022年~2028年Global Automated Visual Field Analyzer Market Size, Share & Industry Trends Analysis Report By End-use, By Type, By Application (Glaucoma, Age-related Macular Degeneration, Scotoma), By Regional Outlook and Forecast, 2022 - 2028 |
||||||
自動視野計の世界市場規模、シェア、産業動向分析レポート:最終用途別、タイプ別、用途別(緑内障、加齢黄斑変性、スコトーマ)、地域別展望と予測、2022年~2028年 |
出版日: 2022年08月31日
発行: KBV Research
ページ情報: 英文 199 Pages
納期: 即納可能
|
自動視野計の世界市場規模は、2028年までに2億2780万米ドルに達し、予測期間中にCAGR7.0%の市場成長率で上昇すると予測されています。
患者は、視野計が提供した特定の光刺激を周辺視野に見つけるよう指示されます。それができない場合、スコトーマや外傷の可能性があります。視野計は、均一な照明が施されたボウル全体に、強さ(明るさ)の異なる一連の白色光刺激を照射します。患者さんは、光が見えたらハンドヘルドのボタンを押して合図します。これにより、網膜が視野内の特定の位置に刺激を見出す能力が評価されます。
これは「デシベル」単位で測定され、網膜感度(dB)と呼ばれます。現在、アナライザーが採用しているSITA(Swedish Interactive Thresholding Algorithm)は、これまでで最も迅速かつ正確な視野評価を可能にしています。その結果を年齢をマッチングさせたデータベースと比較することで、病変の可能性がある疑わしい視力低下や予期せぬ視力低下を明らかにすることができます。本装置は、病態のスクリーニング、モニタリング、診断支援に使用することができます。目的に応じて、様々な調査手法を選択することができます。
COVID-19影響度分析
COVID-19が自動視野計市場にマイナスの影響を与えたのは、眼科検査を含む病院での選択的処置の遅れや感染リスクのような要素があり、眼科クリニックに通う個人の数が減少しているためです。業界を制限しているその他の課題には、価格圧力、眼科医の不足、競争の激化、高コストが含まれます。さらに、予約の減少、特定の治療法の回避、より多くの器具の使用、新しい処置の実践など、臨床的な影響も出てきています。医師と患者のつながりを強化するために、人工知能と遠隔眼科が推奨されています。
市場成長要因
急速な技術進歩とアナライザー技術の発展
現代では、自動フィールドアナライザーに導入されている多くの進歩があります。新しいソフトウェアアルゴリズムが導入され、この機器の複雑な技術におけるこれらの重要な進歩の一つとなっています。製品発表の頻度の急増は、市場の拡大を促進すると予測される主な要因の1つです。最近の技術開発は、さまざまな新しい視覚機能検査の開発につながっています。
医師と患者へのターンアラウンドタイム短縮を提供
自動視野計のターンアラウンドタイムは大幅に短縮され、視野検査の精度は近年とは対照的に向上しています。自動視野計市場で活動するいくつかの市場参加者が行っている多くの努力と取り組みにより、これらの分析装置のターンアラウンドタイムは大幅に短縮されています。ターンアラウンドタイムが短くなったことで、いくつかのクリニックの医師は患者の診断と治療のペースを加速させることができるようになりました。
市場成長要因
分析装置の精度と汎用性の欠如
自動視野計には多くの利点があるが、大きな欠点もあります。自動視野計は、様々な要因でエラーを起こす可能性が高いのです。例えば、自動視野計で行った検査結果は、頭の位置が正しくないために非常に簡単に妨げられることがあります。患者さんの頭の位置が少し動くだけで、検査結果に大きな影響を与えるのです。また、重度の緑内障の患者さんは、正確な診断が非常に難しいのです。
タイプ別の展望
自動視野計市場は、タイプ別に静的型と運動型に二分されます。2021年、キネティックセグメントは自動視野計市場で大きな収益シェアを獲得しました。キネティック視野計は、動く刺激を捉えて正確な結果を出すことができることが、その主な利点の1つです。その主な利点は、検査者と患者の両方の相互作用の増加、より速い周辺検査、およびより良い空間分解能が含まれています。
アプリケーションの展望
アプリケーションに基づき、自動視野計市場は緑内障、加齢黄斑変性症(AMD)、スコトーマ、その他に分別されます。2021年には、緑内障のセグメントが自動視野計市場で最も高い収益シェアを調達しました。緑内障によって目の視神経が損傷し、視力低下や失明を引き起こします。緑内障は、眼球内の通常の液体の圧力が着実に上昇することによって引き起こされます。
エンドユーザー向け展望
エンドユーザー別では、自動視野計市場は、病院、眼科クリニック、その他に区分されます。2021年には、病院セグメントが自動視野計市場で最大の収益シェアを示しました。この業界は、眼に関連する疾患の有病率の増加と自動視野計の技術開発の両方によって牽引されています。
地域別展望
地域別では、自動視野計市場は、北米、欧州、アジア太平洋、LAMEAで分析されています。2021年、北米は自動視野計市場で最大の収益シェアを占めました。これは、同地域の市場プレイヤーの多さと眼疾患有病率の上昇に起因するものです。自動視野計市場は、最先端技術の高い採用率と良心的な償還政策によって牽引されています。
List of Figures
The Global Automated Visual Field Analyzer Market size is expected to reach $227.8 Million by 2028, rising at a market growth of 7.0% CAGR during the forecast period.
An automated visual field analyzer is an automated tool that is very frequently employed by Optometrists, orthoptists, and ophthalmologists to measure the human visual field, especially to identify monocular visual fields. The sort of vision defect is determined by the analyzer's results. As a result, it offers details on where any disease activates or lesion may be located along the visual pathway.
It directs and aids in the diagnosis of the visual disorder affecting the patient. These results are kept on file and utilized to keep tabs on the patient's health and the progression of vision loss. These analyzers examine the patient's whole vertical and horizontal field of peripheral vision, looking for any probable vision problems or blind spots (scotomas). Finding particular scotomas in one's vision can be a sign of a particular kind of brain injury or illness, like a tumor or stroke.
The patient is instructed to locate specific light stimuli that the analyzer has provided in their peripheral vision. If the patient is not able to do so, this may indicate scotomas or trauma. The analyzer emits a sequence of white light stimuli across a bowl that is evenly lit, with different intensities (brightness). The patient presses a button on a handheld device to signal when they see a light. This evaluates the retina's capacity to find a stimulus at particular locations within the visual field.
This is measured in 'decibels' and is known as retinal sensitivity (dB). The Swedish Interactive Thresholding Algorithm, or SITA, which is now used by the analyzer, enables the quickest and most precise visual field assessment to date. The results are then compared to an age-matched database to reveal suspicious and unexpected vision loss that may be a result of pathology. The analyzer can be employed for condition screening, monitoring, and diagnosis support. Depending on the objectives, there are a variety of testing methodologies to choose from.
COVID-19 Impact Analysis
COVID-19 had a negative impact on the automated visual field analyzers market because of elements, like the delay of elective hospital procedures, including eye exams, and the infection risk, which has led to a decline in the number of individuals attending eye clinics. Other challenges that are limiting the industry include a shortage of price pressure, ophthalmologists, escalating competition, and high costs. Additionally, it has had a clinical impact on fewer appointments, avoiding particular treatment alternatives, using more instruments, and putting new procedures into practice. Artificial intelligence and teleophthalmology are recommended for enhancing doctor-patient connections.
Market Growth Factors
Rapid Technological Advancement And Developments In The Analyzer Technology
In the modern era, there is a number of advancements that are being introduced in automated field analyzers. New software algorithms have been introduced, which is one of these significant advancements in the complex technology of this equipment. A surge in the frequency of product launches is one of the main factors projected to fuel the market's expansion. Recent developments in the technology are leading to the development of various novel visual function tests.
Offers Reduced Turnaround Time To Doctors And Patients
The turnaround time for automated visual field analyzers has greatly decreased, and accuracy in visual field testing has increased in contrast to recent years. Due to a number of efforts and initiatives being taken by several market players operating in the automated visual field analyzer market, the turnaround time of these analyzers has been reduced significantly. With the lesser turnaround time, doctors at several clinics are now able to accelerate the pace of diagnosis and treatment of their patients.
Market Growth Factors
Lack Of Precision And Versatility Of Analyzers
Despite a number of benefits of an automated visual field analyzer, there is a major drawback of this technology. Automated visual field analyzers are highly prone to making errors due to a number of factors. For example, the result of a test conducted with the automated field tester can be very easily hampered by incorrect placement of the head. Even a slight movement in the position of the patient's head can completely influence the result. Moreover, patients with severe glaucoma are very hard to be diagnosed accurately.
Type Outlook
On the basis of type, the Automated Visual Field Analyzer Market is bifurcated into Static and Kinetic. In 2021, the kinetic segment garnered a significant revenue share of the automated visual field analyzer market. The ability of kinetic visual field analyzers to capture moving stimuli and deliver precise results is one of its main advantages. Their main advantages include increased interaction between both the examiner and the patient, faster peripheral testing, and better spatial resolution.
Application Outlook
Based on Application, the Automated Visual Field Analyzer Market is segregated into Glaucoma, Age-related Macular Degeneration (AMD), Scotoma, and Others. In 2021, the glaucoma segment procured the highest revenue share of the automated visual field analyzer market. The optic nerve of the eye is damaged by glaucoma, which results in vision loss and blindness. Glaucoma is brought on by the usual fluid pressure in the eyes steadily raising.
End-User Outlook
By End-user, the Automated Visual Field Analyzer Market is segmented into Hospitals, Eye Clinics, and Others. In 2021, the hospitals segment witnessed the largest revenue share of the automated visual field analyzer market. The industry is being driven by both the increased prevalence of eye-related diseases and technological developments in automated visual field analyzers.
Regional Outlook
Region-Wise, the Automated Visual Field Analyzer Market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. In 2021, North America held the biggest revenue share of the automated visual field analyzer market. This can be ascribed to the region's large number of market players and rise in ocular illness prevalence. The market for automated visual field analyzers is being driven by the high adoption of cutting-edge technology and benevolent reimbursement policies.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Topcon Corporation, Carl Zeiss AG, Metall Zug AG, Oculus Optikgerate GmbH, Kowa Company, Ltd., Heidelberg Engineering, Inc., Metrovision SAS, Optopol Technology Sp. z o.o., and MEDA Co., Ltd.
Strategies deployed in Automated Visual Field Analyzer Market
Partnerships, Collaborations and Agreements:
Dec-2019: Topcon partnered with Eastern Ophthalmic and Gold Coast Ophthalmic, two full-line authorized distributors. Under this partnership, Eastern Ophthalmic and Gold Coast Ophthalmic would commercialize Topcon's complete product portfolio, spanning from Topcon's industry-first fully automated OCT/fundus camera to its advanced digital and conventional refraction products and new data management software.
Product Launches and Product Expansions:
Apr-2022: Haag-Streit released the Eyestar 900, an Anterior Chamber Suit. Following this launch, the company aimed to fulfill the rising demand for enhanced results in refractive and cataract surgery. Moreover, the new swept-source OCT-based Eyestar 900 offers versatile tools for refractive and cataract surgery.
Aug-2019: Topcon unveiled the Maestro2, an automated OCT/Fundus camera. The new fully automated OCT Maestro2 can capture non-mydriatic high-resolution, true color fundus photography, OCTA, and OCT with a single click through its 360° rotating intuitive touchscreen and a space-saving design. Moreover, the new product also provides the Hood Report for the function/structure analysis of glaucoma.
Mar-2019: Zeiss introduced a new software upgrade to its Humphrey Field Analyzer. This product expansion aimed to establish 24-2C, a new testing protocol in response to the shift in customers' preference for testing and detection of macular injury within all stages of glaucoma. Moreover, the new software would also streamline and expedite visual field testing.
Dec-2018: Oculus rolled out the Smartfield perimeter. Through this launch, the company aimed to expand its compact visual field testing devices portfolio. The new device is specially optimized for central visual field functional impairment examinations. Furthermore, the new product also leverages an ultra-high luminance LCD display and its lower measurement durations make it compatible with standard screening methods.
Acquisitions and Mergers:
Jul-2020: Topcon Healthcare took over Elektron Eye Technology's Henson range of perimetry products. With this acquisition, the company aimed to leverage the prospect to strategically develop this sector of the product portfolio of the company. In addition, this Henson's product line would also complement the global strategy with the growing emphasis of Topcon on early disease detection and screening.
Market Segments covered in the Report:
By End-use
By Type
By Application
By Geography
Companies Profiled
Unique Offerings from KBV Research